Protein kinase Cα inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens enterotoxin via claudin-4
- 13 December 2011
- journal article
- research article
- Published by Springer Nature in Cell and tissue research
- Vol. 346 (3) , 369-381
Abstract
Protein kinase C (PKC) is overexpressed in cancer, including pancreatic cancer, compared with normal tissue. Moreover, PKCα is considered one of the biomarkers for the diagnosis of cancers. In several human cancers, the claudin tight junction molecules are abnormally regulated and are thus promising molecular targets for diagnosis and therapy with Clostridium perfringens enterotoxin (CPE). In order to investigate the changes of tight junction functions of claudins via PKCα activation in pancreatic cancer cells, the well-differentiated human pancreatic cancer cell line HPAC, with its highly expressed tight junction molecules and well-developed barrier function, was treated with the PKC activator 12-O-tetradecanoylphorbol 13-acetate (TPA). Treatment with TPA modified the activity of phosphoPKCα and caused an increase of the Snail family members Snail, Slug and Smad-interacting protein 1 and a decrease of E-cadherin. In HPAC cells treated with TPA, downregulation of claudin-1 and mislocalization of claudin-4 and occludin around the nuclei were observed, together with a decrease in the numbers of tight junction strands and an increase in phosphorylation of claudin-4. The barrier function and the cytotoxicity of CPE were significantly decreased on TPA treatment. All such changes after TPA treatment were prevented by inhibitors of panPKC and PKCα. These findings suggest that, in human pancreatic cancer cells, PKCα activation downregulates tight junction functions as a barrier and as a receptor of CPE via the modification of claudin-1 and −4 during epithelial to mesenchymal transition-like changes. PKCα inhibitors might represent potential therapeutic agents against human pancreatic cancer cells by use of CPE cytotoxicity via claudin-4.Keywords
This publication has 49 references indexed in Scilit:
- Downregulation of tight junction-associated MARVEL protein marvelD3 during epithelial–mesenchymal transition in human pancreatic cancer cellsExperimental Cell Research, 2011
- Effects of Clostridium perfringens enterotoxin via claudin-4 on normal human pancreatic duct epithelial cells and cancer cellsCellular & Molecular Biology Letters, 2011
- PKCα-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-β1Journal of Experimental & Clinical Cancer Research, 2010
- Transcriptional Control of Tight Junction Proteins via a Protein Kinase C Signal Pathway in Human Telomerase Reverse Transcriptase-Transfected Human Pancreatic Duct Epithelial CellsThe American Journal of Pathology, 2010
- Phorbol ester phorbol‐12‐myristate‐13‐acetate induces epithelial to mesenchymal transition in human prostate cancer ARCaPE cellsThe Prostate, 2010
- Protein kinase Cα: disease regulator and therapeutic targetTrends in Pharmacological Sciences, 2010
- Epithelial-to-Mesenchymal Transition and Resistance to Ingenol 3-Angelate, a Novel Protein Kinase C Modulator, in Colon Cancer CellsCancer Research, 2009
- Phosphorylation of claudin-4 by PKCε regulates tight junction barrier function in ovarian cancer cellsExperimental Cell Research, 2007
- Targeting the protein kinase C family: are we there yet?Nature Reviews Cancer, 2007
- Signalling to and from tight junctionsNature Reviews Molecular Cell Biology, 2003